InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (7 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
7
T+90 hit rate
44%
T+90 mean return
-2.5%
Across 16 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Mueller Brian, Chief Financial Officer. Director active across 1 company, notably Biomarin Pharmaceutical INC. Cumulatively, 29 disclosures have been published. Split: 0 buy · 7 sells. Total volume traded: €2m. History available since 30 April 2021. The latest transaction was disclosed on 14 March 2025 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations29 total
18,497 shares@ US$69.4424.2% of flowCommon StockSEC:0001048477-25-000029:0
11,040 shares0Common StockSEC:0001048477-25-000019:0
588 shares@ US$82.330.9% of flowCommon StockSEC:0001048477-24-000120:0
300 shares@ US$68.6460.4% of flowCommon StockSEC:0001048477-24-000114:0
11,400 shares0Common StockSEC:0001048477-24-000044:0
4,602 shares@ US$88.937.7% of flowCommon StockSEC:0001048477-23-000023:0
9,630 shares0Common StockSEC:0001567619-23-005297:0
12,660 shares0Common StockSEC:0001209191-23-014617:0
2,500 shares@ US$63.103.0% of flowCommon StockSEC:0001567619-23-000965:0
2,500 shares@ US$114.505.4% of flowCommon StockSEC:0001567619-23-000965:1
2,500 shares@ US$63.103.1% of flowCommon StockSEC:0001567619-22-021667:0
1,101 shares@ US$104.502.2% of flowCommon StockSEC:0001567619-22-021363:0
2,139 shares@ US$67.812.8% of flowCommon StockSEC:0001567619-22-021363:1
2,139 shares@ US$104.504.3% of flowCommon StockSEC:0001567619-22-021363:2
3,761 shares@ US$67.815.0% of flowCommon StockSEC:0001567619-22-021363:3
3,761 shares@ US$104.507.6% of flowCommon StockSEC:0001567619-22-021363:4
934 shares@ US$95.091.8% of flowCommon StockSEC:0001567619-22-020937:0
3,500 shares@ US$67.814.7% of flowCommon StockSEC:0001567619-22-015384:0
3,500 shares@ US$94.506.6% of flowCommon StockSEC:0001567619-22-015384:1
7,337 shares@ US$89.5013.2% of flowCommon StockSEC:0001567619-22-013907:0
576 shares@ US$83.920.0004% mcap13.3% of flowCommon StockSEC:0001567619-22-013594:0
340 shares@ US$62.4070.0002% mcap5.8% of flowCommon StockSEC:0001567619-22-009717:0
11,040 shares0Common StockSEC:0001567619-22-007185:0
1,072 shares@ US$87.7759.0% of flowCommon StockSEC:0001567619-22-002765
1,072 shares@ US$87.770.0007% mcap23.9% of flowCommon StockSEC:0001567619-22-002765:0
25 of 29 declarations
About Mueller Brian
Brian Mueller is the Executive Vice President and Chief Financial Officer at BioMarin Pharmaceutical Inc. In this role, he is responsible for the company's financial management and the development of financial strategies. Mueller brings significant expertise in the pharmaceutical sector, contributing to the company's growth and sustainability.
